Verinetics, Inc. announced today the listing of its first product, DispenSecur™ v1, as a Class I Medical Device with the US Food and Drug Administration. DispenSecur™ is intended to support Opioid Treatment Program (OTP) providers and the individuals in recovery they serve.
